AbbVie (ABBV) Options Chain & Prices $233.42 +3.23 (+1.40%) Closing price 10/7/2025 03:59 PM EasternExtended Trading$233.92 +0.49 (+0.21%) As of 10/7/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Options Chain Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ABBV Put and Call Options List 1/21/2028 9/17/2027 6/17/2027 1/15/2027 10/16/2026 9/18/2026 6/18/2026 5/15/2026 3/20/2026 2/20/2026 1/16/2026 12/19/2025 11/21/2025 11/14/2025 11/7/2025 10/31/2025 10/24/2025 10/17/2025 10/10/2025 Options Date Put and Call Options Put Options Call Options Options Type All In The Money Out of The Money Moneyness With Volume Without Volume All Volume Strike Price Min Strike Price Max Export to Excel ExpiresStrike PriceClose PricePut/CallVolumeVolume AskVolume BidOpen InterestImplied VolatilityDeltaTrades10/10/2025$190.00$43.198Call1 - - 1(+0)72.70% (+8.96%)0.999304110/10/2025$200.00$33.209Call2 - - 20(-1)60.17% (+7.89%)0.997846110/10/2025$205.00$28.218Call2 - 120(+0)54.10% (+7.39%)0.996014210/10/2025$207.50$0.019Put1 - - 26(-1)51.12% (+7.15%)-0.005727110/10/2025$210.00$0.026Put20 - 1091(+7)48.18% (+6.92%)-0.008054510/10/2025$212.50$0.037Put1 - - 155(+2)45.30% (+6.70%)-0.011614110/10/2025$215.00$18.264Call11 - 139(+1)42.48% (+6.49%)0.982976110/10/2025$220.00$0.131Put1937208(+40)37.20% (+6.04%)-0.0417011210/10/2025$220.00$13.344Call23 - - 163(-1)37.20% (+6.04%)0.958579610/10/2025$222.50$0.219Put1223193(+19)34.86% (+5.68%)-0.0681577 Get the Latest News and Ratings for ABBV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AbbVie and its competitors with MarketBeat's FREE daily newsletter. 10/10/2025$222.50$10.933Call1 - - 218(+0)34.86% (+5.68%)0.932243110/10/2025$225.00$0.386Put1512588377(+129)32.89% (+5.17%)-0.1142952910/10/2025$225.00$8.601Call3012 - 316(-24)32.89% (+5.17%)0.8864391110/10/2025$227.50$0.704Put611041100(+28)31.45% (+4.61%)-0.1915712210/10/2025$227.50$6.419Call32410108(-33)31.45% (+4.61%)0.809892010/10/2025$230.00$1.279Put638815271242(+513)30.53% (+4.15%)-0.3072183410/10/2025$230.00$4.490Call1056125777(+54)30.53% (+3.44%)0.6956134710/10/2025$232.50$2.212Put27726410763(+2)30.05% (+3.88%)-0.4544875410/10/2025$232.50$2.916Call905230562631(+447)30.05% (+3.88%)0.5503913710/10/2025$235.00$3.565Put135 - 109(-29)29.98% (+3.84%)-0.610755510/10/2025$235.00$1.756Call1,996596360373(+106)32.43% (+5.56%)0.39644523610/10/2025$237.50$5.311Put1 - - 231(-275)30.17% (+3.99%)-0.749292110/10/2025$237.50$0.983Call457283131449(+31)30.17% (+3.99%)0.25986810210/10/2025$240.00$0.510Call30624938362(+12)30.43% (+4.10%)0.1553019510/10/2025$242.50$0.247Call854221888(+9)30.78% (+4.00%)0.0852383010/10/2025$245.00$0.119Call1105418392(-17)31.51% (+3.87%)0.0450482410/10/2025$247.50$0.063Call3229193(+0)32.91% (+4.10%)0.024964910/10/2025$250.00$0.037Call817182(+2)34.72% (+4.65%)0.014834210/10/2025$255.00$0.012Call716339(+10)37.76% (+4.85%)0.0050272End-of-day options data provided by Trade Alert and Intrinio. Related Companies and Tools Related Companies Amgen Options Gilead Sciences Options Moderna Options Abbott Laboratories Options Bristol Myers Squibb Options Johnson & Johnson Options Eli Lilly and Company Options Merck & Co., Inc. Options Pfizer Options Zoetis Options Options Chain Tools Short Interest TrackerShort Interest IncreasesShort Interest DecreasesUnusual Call VolumeUnusual Put Volume This page (NYSE:ABBV) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGet my No. 1 gold stock nowGold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks sa...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredU.S. Government Blocked NVIDIA’s Buyout… Here’s WhyThe U.S. government doesn't normally block billion-dollar tech deals. But when NVIDIA tried to acquire this...Behind the Markets | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbbVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbbVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
